← Back to Clinical Trials
Recruiting NCT06456268

VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition ACL
Sponsor Columbia University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 130
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2026-06
Completion 2026-11-30
Interventions
VibraCool mechanical stimulation and neuromodulatory therapeutic deviceCryocompression (Game Ready, Bregs) deviceStandard ice packs

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this project is to test the effects of the VibraCool mechanical stimulation neuromodulatory therapeutic device on post-operative pain and opioid use following anterior crucitate ligament reconstruction (ACLR), and thus residual opioids in circulation.

Eligibility Criteria

Inclusion Criteria: * Underwent ACL reconstruction Exclusion Criteria: * Pediatric iliotibial band ACL reconstruction (known to cause significantly more pain) * Non-english speakers (limitations of our study group)

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE ACL TRIALS
}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology